Clinical Trial Update: Vaccine Therapy in Treating Patients With Myelodysplastic Syndromes [EARLY_Phase 1]

View source ↗

Summary

Early-phase clinical trial update on a vaccine therapy for myelodysplastic syndromes (Phase 1; terminated; results posted).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Myelodysplastic Syndromes | EARLY_Phase 1 | Status: TERMINATED | Results posted: 2018-11-16